Selected research
Industry Research
Standard Peptide Custom Synthesis Service Industry Research Report 2026
Market perspective
The global Standard Peptide Custom Synthesis Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Standard Peptide Custom Synthesis Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Standard Peptide Custom Synthesis Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Standard Peptide Custom Synthesis Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Standard Peptide Custom Synthesis Service include Bachem, PolyPeptide, GL Biochem, Xinbang, Hybio, USVPeptides, Thermofischer, ScinoPharm and Genscript, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Standard Peptide Custom Synthesis Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Standard Peptide Custom Synthesis Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Standard Peptide Custom Synthesis Service Market by Company
Bachem
PolyPeptide
GL Biochem
Xinbang
Hybio
USVPeptides
Thermofischer
ScinoPharm
Genscript
AnaSpec
New England Peptide
CPC Scientific
JPT
21st Century Bio
LifeTein
Proimmune
Biomatik
Standard Peptide Custom Synthesis Service Segment by Type
CRO Peptides
CMO Peptides
Generic API Peptides
Standard Peptide Custom Synthesis Service Segment by Application
Commercial
Academic Research
Standard Peptide Custom Synthesis Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Standard Peptide Custom Synthesis Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Standard Peptide Custom Synthesis Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Standard Peptide Custom Synthesis Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Standard Peptide Custom Synthesis Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- CRO Peptides
- CMO Peptides
- Generic API Peptides
Applications
- Commercial
- Academic Research
Companies covered
- Bachem
- PolyPeptide
- GL Biochem
- Xinbang
- Hybio
- USVPeptides
- Thermofischer
- ScinoPharm
- Genscript
- AnaSpec
- New England Peptide
- CPC Scientific
- JPT
- 21st Century Bio
- LifeTein
- Proimmune
- Biomatik
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Standard Peptide Custom Synthesis Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 CRO Peptides
- 2.2.3 CMO Peptides
- 2.2.4 Generic API Peptides
- 2.3 Standard Peptide Custom Synthesis Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Commercial
- 2.3.3 Academic Research
- 2.4 Assumptions and Limitations
3 Standard Peptide Custom Synthesis Service Breakdown Data by Type
- 3.1 Global Standard Peptide Custom Synthesis Service Historic Market Size by Type (2021-2026)
- 3.2 Global Standard Peptide Custom Synthesis Service Forecasted Market Size by Type (2027-2032)
4 Standard Peptide Custom Synthesis Service Breakdown Data by Application
- 4.1 Global Standard Peptide Custom Synthesis Service Historic Market Size by Application (2021-2026)
- 4.2 Global Standard Peptide Custom Synthesis Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Standard Peptide Custom Synthesis Service Market Perspective (2021-2032)
- 5.2 Global Standard Peptide Custom Synthesis Service Growth Trends by Region
- 5.2.1 Global Standard Peptide Custom Synthesis Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Standard Peptide Custom Synthesis Service Historic Market Size by Region (2021-2026)
- 5.2.3 Standard Peptide Custom Synthesis Service Forecasted Market Size by Region (2027-2032)
- 5.3 Standard Peptide Custom Synthesis Service Market Dynamics
- 5.3.1 Standard Peptide Custom Synthesis Service Industry Trends
- 5.3.2 Standard Peptide Custom Synthesis Service Market Drivers
- 5.3.3 Standard Peptide Custom Synthesis Service Market Challenges
- 5.3.4 Standard Peptide Custom Synthesis Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Standard Peptide Custom Synthesis Service Players by Revenue
- 6.1.1 Global Top Standard Peptide Custom Synthesis Service Players by Revenue (2021-2026)
- 6.1.2 Global Standard Peptide Custom Synthesis Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Standard Peptide Custom Synthesis Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Standard Peptide Custom Synthesis Service Head Office and Area Served
- 6.4 Global Standard Peptide Custom Synthesis Service Players, Product Type & Application
- 6.5 Global Standard Peptide Custom Synthesis Service Manufacturers Established Date
- 6.6 Global Standard Peptide Custom Synthesis Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Standard Peptide Custom Synthesis Service Market Size (2021-2032)
- 7.2 North America Standard Peptide Custom Synthesis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Standard Peptide Custom Synthesis Service Market Size by Country (2021-2026)
- 7.4 North America Standard Peptide Custom Synthesis Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Standard Peptide Custom Synthesis Service Market Size (2021-2032)
- 8.2 Europe Standard Peptide Custom Synthesis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Standard Peptide Custom Synthesis Service Market Size by Country (2021-2026)
- 8.4 Europe Standard Peptide Custom Synthesis Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Standard Peptide Custom Synthesis Service Market Size (2021-2032)
- 9.2 Asia-Pacific Standard Peptide Custom Synthesis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Standard Peptide Custom Synthesis Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Standard Peptide Custom Synthesis Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Standard Peptide Custom Synthesis Service Market Size (2021-2032)
- 10.2 South America Standard Peptide Custom Synthesis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Standard Peptide Custom Synthesis Service Market Size by Country (2021-2026)
- 10.4 South America Standard Peptide Custom Synthesis Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Standard Peptide Custom Synthesis Service Market Size (2021-2032)
- 11.2 Middle East & Africa Standard Peptide Custom Synthesis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Standard Peptide Custom Synthesis Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Standard Peptide Custom Synthesis Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Bachem
- 12.1.1 Bachem Company Information
- 12.1.2 Bachem Business Overview
- 12.1.3 Bachem Revenue in Standard Peptide Custom Synthesis Service Business (2021-2026)
- 12.1.4 Bachem Standard Peptide Custom Synthesis Service Product Portfolio
- 12.1.5 Bachem Recent Developments
- 12.2 PolyPeptide
- 12.2.1 PolyPeptide Company Information
- 12.2.2 PolyPeptide Business Overview
- 12.2.3 PolyPeptide Revenue in Standard Peptide Custom Synthesis Service Business (2021-2026)
- 12.2.4 PolyPeptide Standard Peptide Custom Synthesis Service Product Portfolio
- 12.2.5 PolyPeptide Recent Developments
- 12.3 GL Biochem
- 12.3.1 GL Biochem Company Information
- 12.3.2 GL Biochem Business Overview
- 12.3.3 GL Biochem Revenue in Standard Peptide Custom Synthesis Service Business (2021-2026)
- 12.3.4 GL Biochem Standard Peptide Custom Synthesis Service Product Portfolio
- 12.3.5 GL Biochem Recent Developments
- 12.4 Xinbang
- 12.4.1 Xinbang Company Information
- 12.4.2 Xinbang Business Overview
- 12.4.3 Xinbang Revenue in Standard Peptide Custom Synthesis Service Business (2021-2026)
- 12.4.4 Xinbang Standard Peptide Custom Synthesis Service Product Portfolio
- 12.4.5 Xinbang Recent Developments
- 12.5 Hybio
- 12.5.1 Hybio Company Information
- 12.5.2 Hybio Business Overview
- 12.5.3 Hybio Revenue in Standard Peptide Custom Synthesis Service Business (2021-2026)
- 12.5.4 Hybio Standard Peptide Custom Synthesis Service Product Portfolio
- 12.5.5 Hybio Recent Developments
- 12.6 USVPeptides
- 12.6.1 USVPeptides Company Information
- 12.6.2 USVPeptides Business Overview
- 12.6.3 USVPeptides Revenue in Standard Peptide Custom Synthesis Service Business (2021-2026)
- 12.6.4 USVPeptides Standard Peptide Custom Synthesis Service Product Portfolio
- 12.6.5 USVPeptides Recent Developments
- 12.7 Thermofischer
- 12.7.1 Thermofischer Company Information
- 12.7.2 Thermofischer Business Overview
- 12.7.3 Thermofischer Revenue in Standard Peptide Custom Synthesis Service Business (2021-2026)
- 12.7.4 Thermofischer Standard Peptide Custom Synthesis Service Product Portfolio
- 12.7.5 Thermofischer Recent Developments
- 12.8 ScinoPharm
- 12.8.1 ScinoPharm Company Information
- 12.8.2 ScinoPharm Business Overview
- 12.8.3 ScinoPharm Revenue in Standard Peptide Custom Synthesis Service Business (2021-2026)
- 12.8.4 ScinoPharm Standard Peptide Custom Synthesis Service Product Portfolio
- 12.8.5 ScinoPharm Recent Developments
- 12.9 Genscript
- 12.9.1 Genscript Company Information
- 12.9.2 Genscript Business Overview
- 12.9.3 Genscript Revenue in Standard Peptide Custom Synthesis Service Business (2021-2026)
- 12.9.4 Genscript Standard Peptide Custom Synthesis Service Product Portfolio
- 12.9.5 Genscript Recent Developments
- 12.10 AnaSpec
- 12.10.1 AnaSpec Company Information
- 12.10.2 AnaSpec Business Overview
- 12.10.3 AnaSpec Revenue in Standard Peptide Custom Synthesis Service Business (2021-2026)
- 12.10.4 AnaSpec Standard Peptide Custom Synthesis Service Product Portfolio
- 12.10.5 AnaSpec Recent Developments
- 12.11 New England Peptide
- 12.11.1 New England Peptide Company Information
- 12.11.2 New England Peptide Business Overview
- 12.11.3 New England Peptide Revenue in Standard Peptide Custom Synthesis Service Business (2021-2026)
- 12.11.4 New England Peptide Standard Peptide Custom Synthesis Service Product Portfolio
- 12.11.5 New England Peptide Recent Developments
- 12.12 CPC Scientific
- 12.12.1 CPC Scientific Company Information
- 12.12.2 CPC Scientific Business Overview
- 12.12.3 CPC Scientific Revenue in Standard Peptide Custom Synthesis Service Business (2021-2026)
- 12.12.4 CPC Scientific Standard Peptide Custom Synthesis Service Product Portfolio
- 12.12.5 CPC Scientific Recent Developments
- 12.13 JPT
- 12.13.1 JPT Company Information
- 12.13.2 JPT Business Overview
- 12.13.3 JPT Revenue in Standard Peptide Custom Synthesis Service Business (2021-2026)
- 12.13.4 JPT Standard Peptide Custom Synthesis Service Product Portfolio
- 12.13.5 JPT Recent Developments
- 12.14 21st Century Bio
- 12.14.1 21st Century Bio Company Information
- 12.14.2 21st Century Bio Business Overview
- 12.14.3 21st Century Bio Revenue in Standard Peptide Custom Synthesis Service Business (2021-2026)
- 12.14.4 21st Century Bio Standard Peptide Custom Synthesis Service Product Portfolio
- 12.14.5 21st Century Bio Recent Developments
- 12.15 LifeTein
- 12.15.1 LifeTein Company Information
- 12.15.2 LifeTein Business Overview
- 12.15.3 LifeTein Revenue in Standard Peptide Custom Synthesis Service Business (2021-2026)
- 12.15.4 LifeTein Standard Peptide Custom Synthesis Service Product Portfolio
- 12.15.5 LifeTein Recent Developments
- 12.16 Proimmune
- 12.16.1 Proimmune Company Information
- 12.16.2 Proimmune Business Overview
- 12.16.3 Proimmune Revenue in Standard Peptide Custom Synthesis Service Business (2021-2026)
- 12.16.4 Proimmune Standard Peptide Custom Synthesis Service Product Portfolio
- 12.16.5 Proimmune Recent Developments
- 12.17 Biomatik
- 12.17.1 Biomatik Company Information
- 12.17.2 Biomatik Business Overview
- 12.17.3 Biomatik Revenue in Standard Peptide Custom Synthesis Service Business (2021-2026)
- 12.17.4 Biomatik Standard Peptide Custom Synthesis Service Product Portfolio
- 12.17.5 Biomatik Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst